Sangamo launches auction for ST-503 pain program as Chapter 11 asset sales close with $163.55 million proceeds
Bitget2026/10/13 20:01- Sangamo set a fourth-quarter 2026 deadline for an auction of its clinical-stage ST-503 chronic neuropathic pain program.
- Asset sales completed through a court-supervised Section 363 process generated USD 163.55 million in gross cash proceeds.
- PTC bought the Fabry disease program ST-920 for USD 111 million in cash, with up to USD 100 million in milestone payments.
- Lilly acquired Sangamo’s capsid delivery, zinc finger and MINT platforms, with the ST-506 prion disease program, for USD 50 million in cash.
- Proceeds were used to repay all outstanding amounts under the debtor-in-possession financing facility provided by Future Solutions.
Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.
You may also like
Boeing (BA.US) Max 10 certification expected to be announced next week, adding new leverage for debt relief
The Boeing 737 Max 10 has completed key certification meetings and could be approved as early as next week. As Boeing's largest variant to rival Airbus, this model will help airlines replace aging 757s and is expected to become a cash cow for Boeing to reduce its debt.

Foreign holdings of US Treasuries rebounded in August, with UK holdings surpassing $1 trillion for the first time
In August, foreign holdings of U.S. Treasury bonds increased by over 83 billions USD, with Canada and Belgium leading the increase; meanwhile, holdings by Japan and China continued to decline to multi-year lows, and for the first time, the UK's holdings surpassed 1 trillion USD.

Strive's bitcoin holdings increased to 35,595, and TD Cowen raised its target price to $56.

New York Federal Reserve Survey: Service Sector Price Increases Hit Fastest Pace Since 2022, Business Activity Index Drops to Lowest Since March
A survey released by the New York Fed on Friday shows that in October, sales prices for service sector firms increased at the fastest pace since 2022, with input costs remaining robust and supply conditions continuing to deteriorate. Businesses’ pessimism about the commercial outlook has significantly intensified, with the overall business activity index falling by 12 points from the previous month to minus 20.7, marking the weakest reading since March.
